Beijing Wantai Biological Pharmacy Enterprise's (SHA:603392) net loss attributable to shareholders in the first half narrowed to 128.3 million yuan from 144 million yuan a year earlier, according to a Shanghai bourse filing on Thursday.
Loss per share was 0.10 yuan, compared to 0.11 yuan in the previous year.
Operating revenue jumped 24% year on year to 1.05 billion yuan from 843.6 million yuan.